NEC laboratories avanza en la investigación de vacunas terapéuticas contra el cáncer con un nuevo modelo de inteligencia artificial llamado Attentive Variational Information Bottleneck

Posted on by

HEIDELBERG, Alemania, 27 de julio de 2023 /PRNewswire/ — NEC Laboratories Europe y NEC Laboratories America han desarrollado un nuevo modelo de inteligencia artificial denominado Attentive Variational Information Bottleneck (AVIB), que supone un avance en el desarrollo de vacunas…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.